Relx Plc (NYSE:RELX) Stock Holdings Reduced by Invesco Ltd.

Invesco Ltd. decreased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 876,417 shares of the technology company's stock after selling 44,358 shares during the period. Invesco Ltd.'s holdings in Relx were worth $39,807,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new stake in Relx during the fourth quarter worth approximately $44,516,000. Bank of Montreal Can lifted its position in shares of Relx by 290.3% during the 4th quarter. Bank of Montreal Can now owns 886,758 shares of the technology company's stock valued at $40,277,000 after acquiring an additional 659,547 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company's stock worth $89,420,000 after acquiring an additional 658,655 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Relx in the 4th quarter worth $9,920,000. Finally, ABC Arbitrage SA acquired a new stake in shares of Relx during the fourth quarter worth $6,296,000. Institutional investors and hedge funds own 15.02% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Redburn Atlantic started coverage on shares of Relx in a report on Wednesday, January 8th. They issued a "buy" rating for the company. Morgan Stanley restated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. The Goldman Sachs Group started coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. Finally, StockNews.com downgraded shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy".

Relx Stock Up 2.0 %

NYSE:RELX traded up $1.03 on Tuesday, hitting $53.10. 1,299,940 shares of the company's stock traded hands, compared to its average volume of 718,841. The firm has a 50-day moving average price of $49.41 and a 200-day moving average price of $48.09. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a market cap of $98.28 billion, a PE ratio of 28.55, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. Relx Plc has a 1 year low of $40.25 and a 1 year high of $53.15.

Relx Increases Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be paid a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. This is a positive change from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is currently 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.